MCL

This month's microlearning delves into how laboratories can leverage kaizen events to seize continuous improvement opportunities. Questions? Contact us: mcleducation@mayo.edu

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, Isak joins the Mayo Clinic Laboratories outreach team — Jane Hermansen, Ellen Dijkman Dulkes, and Brianne Newton — to talk about his unique experience in joining the lab profession at a young age.

In this month’s episode of Lab Medicine Rounds, Justin Kreuter, M.D., interviews Jeffrey Winters, M.D., the medical director of the Therapeutic Apheresis Treatment Unit at Mayo Clinic for Myasthenia Gravis Awareness Month.

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming July 4th holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.

In a constrained staffing environment, how can an outreach program effectively meet customer needs? Through creativity, collaboration, and shared services, there can be multiple solutions to provide the support needed by the laboratory staff and the people they serve.

PACE/State of FL - The latest updates in Alzheimer’s disease diagnostic criteria as well as a comprehensive review of the laboratory testing landscape.

Mayo Clinic laboratory experts share case studies that challenge you to test your knowledge of anatomic and clinical pathology.

Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating conditions associated with these antibodies.

In this episode of #LabMedicineRounds, Justin Kreuter, M.D., interviews Ashima Makol, M.B.B.S., for National Scleroderma Awareness Month, including a discussion about lab medicine's important role in diagnosis.

Divyanshu Dubey, M.B.B.S., explains how Mayo Clinic Laboratories' unique PDE10A and TRIM46 tests facilitate the management of central nervous system disorders triggered by cancers. Early diagnosis and treatment are important for managing disabling neurological symptoms and malignancy.

This page includes updates posted to Mayo Clinic Labs during the month of May.

Central nervous system infections, such as meningitis and encephalitis, can be devastating for affected patients. While specific treatments are available for some of these infections, it first requires identifying the precise cause of infection. To meet that need, Mayo Clinic Laboratories has developed a metagenomics assay that can identify more than 1,000 pathogenic organisms in cerebrospinal fluid. The innovative assay, which uses an approach known as shotgun metagenomic sequencing, is one of the only such tests currently available.

This month's microlearning explores the significant impact of psychological safety on employees in the workplace.